指南与共识血管炎

EULAR 大血管炎影像学推荐对巨细胞动脉炎诊断的影响:ARTESER 登记研究结果

Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register.
指南 / 共识 · RMD Open · 2022-01-01

ARTESER 为西班牙风湿病学会支持的多中心观察性回顾性研究,纳入 2013 年 6 月 1 日至 2019 年 3 月 29 日 26 家医院诊断的 1675 例巨细胞动脉炎患者,评估诊断检查的使用情况。结果显示活检仍是最常用确诊手段(46.3% 阳性),但 2018 年 EULAR 推荐发布后超声使用从 25.8% 升至 52.9%,已取代活检成为一线诊断检查,活检降至 33.3%。

要点

  • 1675 例巨细胞动脉炎患者中,颞动脉活检阳性 776 例(46.3%),超声阳性 503 例(30.0%)。
  • 2013 至 2019 年,超声使用从 25.8% 升至 52.9%,PET 从 12.3% 升至 19.6%,活检从 50.3% 降至 33.3%。
  • 2018 年 EULAR 推荐发布后,超声已取代活检成为一线诊断检查,活检在三分之一、PET 在五分之一病例中实施。

核心结论

  • 活检是确认巨细胞动脉炎最广泛使用的诊断检查,但近年影像学作为诊断工具的使用有所增长。
  • 2018 年 EULAR 推荐发布后,超声已取代活检成为一线诊断检查,活检在三分之一、PET 在五分之一病例中实施。

研究设计与样本

  • ARTESER 为西班牙风湿病学会支持的多中心观察性回顾性研究,在 26 家医院开展。
  • 纳入 2013 年 6 月 1 日至 2019 年 3 月 29 日诊断的 1675 例巨细胞动脉炎患者,平均年龄 76.9±8.1 岁,女性 1178 例(70.3%)。
  • 诊断金标准为主诊医师依据临床标准并结合实验室检查、影像学(超声、PET、MRI/CT 血管成像)及可获得的颞动脉活检所作判断。

主要发现

  • 776 例患者颞动脉活检阳性(46.3%),503 例超声阳性(30.0%),245 例 PET 阳性(14.6%),64 例 MRI/CT 血管成像阳性(3.8%)。
  • 2013 至 2019 年,诊断中超声使用从 25.8% 增至 52.9%,PET 从 12.3% 增至 19.6%。
  • 同期颞动脉活检使用从 50.3% 降至 33.3%。

临床怎么用

  • 2018 年 EULAR 推荐发布后,本登记研究中超声已取代活检成为一线诊断检查,活检在三分之一病例中实施。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The main study objective was to determine how giant cell arteritis (GCA) is diagnosed in our clinical practice and whether the EULAR recommendations have influenced the diagnostic procedures used. METHODS: ARTEritis of the Rheumatology Spanish Society -Sociedad Española de Reumatología (ARTESER) is a multicentre observational retrospective study conducted in 26 hospitals with support from the Spanish Society of Rheumatology. All patients diagnosed with GCA between 1 June 2013 and 29 March 2019 were included. The gold standard for the diagnosis of GCA was the judgement of the physician in charge, according to clinical criteria, supported by data available from laboratory tests, imaging studies (ultrasound, positron emission tomography (PET) and MRI/CT angiography) and temporal artery biopsy (TAB) when available. RESULTS: We included 1675 patients with GCA (mean age±SD (76.9±8.1) years, 1178 women (70.3%)). Of these, 776 patients had a positive TAB (46.3%), 503 (30.0%) positive ultrasound, 245 positive PET (14.6%) and 64 positive MRI/CT angiography (3.8%). These percentages changed substantially over the study. From 2013 to 2019, the use of ultrasound in diagnosis grew from 25.8% to 52.9% and PET from 12.3% to 19.6%, while use of TAB decreased from 50.3% to 33.3%. CONCLUSIONS: Biopsy was the most widely used diagnostic test for confirming GCA, but use of imaging as a diagnostic tool has grown in recent years. Following publication of the 2018 EULAR recommendations, ultrasound has displaced biopsy as the first-line diagnostic test; TAB was performed in a third and PET in a fifth of cases.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. De Miguel E, Sanchez-Costa JT, Estrada P, et al. Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register. RMD Open. 2022. PMID: 36597988. doi:10.1136/rmdopen-2022-002507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。